Evidence map›Paper›PMID 42506547›Full record

ReviewJournal of functional biomaterials2026

Amniotic Membrane-Derived Factors in Immunomodulation and Regenerative Medicine: Current Evidence and Emerging Perspectives in Biomaterials and 3D Bioprinting.

Hristina Obradović, Ivana Gazikalović, Ivana Okić Đorđević, Sanja Momčilović, Dragana Aleksandrović, Nikola Jeftić, Aleksandra Jauković

Abstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hristina ObradovićGroup for Hematology and Stem Cells, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-4626-7184
Ivana GazikalovićInnovation Center of the Faculty of Technology and Metallurgy, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-6481-8966
Ivana Okić ĐorđevićGroup for Hematology and Stem Cells, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-3552-1546
Sanja MomčilovićGroup for Neuroendocrinology, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-2044-8155
Dragana AleksandrovićGroup for Hematology and Stem Cells, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0009-0002-1050-378X
Nikola JeftićInstitute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-5768-6256
Aleksandra JaukovićGroup for Hematology and Stem Cells, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.

Funding

Ministry of Science, Technological Development, and Innovation 451-03-33/2026-03/200015Ministry of Science, Technological Development, and Innovation 451-03-33/2026-03/200287Science Fund of the Republic of Serbia No 11073
6 · The paper itself

Abstract

Human placenta-derived amniotic membrane (hAM) and its derivatives have attracted growing interest as bioactive materials for tissue engineering, regenerative medicine, and biomaterial design. This review summarizes the anatomical and cellular characteristics of hAM and examines the interplay between its regenerative and immunomodulatory properties. Key hAM-derived biomolecules are discussed, with an emphasis on their roles in immune regulation, angiogenesis, extracellular matrix remodeling, and tissue repair across diverse regenerative contexts. Current applications of hAM-based materials in tissue engineering and regenerative biomaterials are reviewed, including emerging studies involving soft tissue applications. In addition, recent efforts to integrate hAM derivatives into 3D bioprinting approaches are examined, including their use as bioink components or biofunctional additives to hydrogel-based systems. Although studies involving hAM-based bioprinted constructs remain limited, the available findings suggest promising regenerative, proangiogenic, and bioactive effects. Challenges related to material processing, printability, standardization, and reproducibility are also discussed. Overall, this review highlights the biomaterial potential of hAM derivatives and their emerging relevance to biofabrication strategies aimed at developing biologically instructive constructs for regenerative medicine.

Indexed as

3D bioprintingamniotic membranebiomaterialsimmunomodulationregenerative medicinetissue engineering

Identifiers

PMID42506547
PMCPMC13412840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.